213 filings
Page 4 of 11
8-K
ecosq48l11 3n
6 Oct 22
Evofem Biosciences Announces Uplisting to OTCQB
4:16pm
8-K
wjzz1kjfpz5acykt9as
5 Oct 22
Regulation FD Disclosure
4:05pm
8-K
tabt07jd6l
16 Sep 22
Evofem Announces Successful Debt Restructuring
6:00am
8-K
4tr4nml5bgtx
10 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:52am
8-K
8g5h ze4cnq
4 Aug 22
Regulation FD Disclosure
5:01pm
8-K
7jzrmsbs3q3ggn9k
4 Aug 22
Evofem Biosciences Announces Strong Second Quarter 2022
4:38pm
8-K
3to8vw2rqo nu
3 Aug 22
Evofem Biosciences Strengthens Board of Directors
8:24am
8-K
lbcrgx
14 Jun 22
Other Events
4:15pm
8-K
ai63c47b7zkem fo1tnd
31 May 22
Entry into a Material Definitive Agreement
4:02pm
8-K
y8r1q96a6q9 c24
26 May 22
Regulation FD Disclosure
2:16pm
8-K
qalu1k0
20 May 22
Evofem Biosciences Announces Proposed Public Offering
7:55pm
8-K
2vd04 f5vyb71k
20 May 22
Termination of a Material Definitive Agreement
6:01am
8-K
qz6mnx
12 May 22
Regulation FD Disclosure
8:01am
8-K
o9m0drql64
5 May 22
Evofem Biosciences Announces 1-for-15 Reverse Stock Split
9:03am
8-K
voe a6i786p
4 May 22
Evofem Biosciences Reports First Quarter 2022
4:05pm
8-K
hfake9fjtfuiyl
7 Apr 22
Continued Listing Subject to Receipt of Shareholder Approval for the Reverse Stock Split of
6:51am
8-K
f2wbmr8lw
6 Apr 22
Entry into a Material Definitive Agreement
7:36pm
8-K
4s1bwz0kl2st3d
24 Mar 22
Entry into a Material Definitive Agreement
4:03pm
8-K
la8pf 2ro
21 Mar 22
Entry into a Material Definitive Agreement
4:35pm
8-K
itbsoiexeg otx5ut
3 Mar 22
Evofem Biosciences Reports Fourth Quarter and Year-End 2021
4:11pm